These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 23819647

  • 1. Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single-centre experience.
    Röhr SB, Sauer H, Gortner L, Gräber S, Meyer S.
    Acta Paediatr; 2013 Oct; 102(10):e436. PubMed ID: 23819647
    [No Abstract] [Full Text] [Related]

  • 2. Non-neurological, steroid-related adverse events in very low birth weight infants: a prospective audit.
    Röhr SB, Sauer H, Gottschling S, Abdul-Khaliq H, Gortner L, Nunold H, Gräber S, Meyer S.
    Swiss Med Wkly; 2014 Oct; 144():w13954. PubMed ID: 24706463
    [Abstract] [Full Text] [Related]

  • 3. Update on Postnatal Steroids.
    Halliday HL.
    Neonatology; 2017 Oct; 111(4):415-422. PubMed ID: 28538237
    [Abstract] [Full Text] [Related]

  • 4. Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.
    Dani C, Bertini G, Simone P, Rubaltelli FF.
    Pediatrics; 2006 May; 117(5):1866-7. PubMed ID: 16651362
    [No Abstract] [Full Text] [Related]

  • 5. [Transient hypertrophic cardiomyopathy due to dexamethasone therapy in a premature infant].
    Pokela ML.
    Duodecim; 1995 May; 111(14):1310-3. PubMed ID: 9244681
    [No Abstract] [Full Text] [Related]

  • 6. Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone.
    Karemaker R, Heijnen CJ, Veen S, Baerts W, Samsom J, Visser GH, Kavelaars A, van Doornen LJ, van Bel F.
    Pediatr Res; 2006 Dec; 60(6):745-50. PubMed ID: 17065571
    [Abstract] [Full Text] [Related]

  • 7. Cardiac effects of dexamethasone in very low birth weight infants.
    Bensky AS, Kothadia JM, Covitz W.
    Pediatrics; 1996 Jun; 97(6 Pt 1):818-21. PubMed ID: 8657520
    [Abstract] [Full Text] [Related]

  • 8. Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up.
    Rademaker KJ, de Vries LS, Uiterwaal CS, Groenendaal F, Grobbee DE, van Bel F.
    Arch Dis Child Fetal Neonatal Ed; 2008 Jan; 93(1):F58-63. PubMed ID: 17848504
    [Abstract] [Full Text] [Related]

  • 9. Newborn lung treatment poses risk of intestinal perforation.
    J Am Coll Surg; 2001 Mar; 192(3):425-6. PubMed ID: 11245391
    [No Abstract] [Full Text] [Related]

  • 10. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity.
    Odd DE, Armstrong DL, Teele RL, Kuschel CA, Harding JE.
    J Paediatr Child Health; 2004 Mar; 40(5-6):282-9. PubMed ID: 15151582
    [Abstract] [Full Text] [Related]

  • 11. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age.
    Karemaker R, Kavelaars A, ter Wolbeek M, Tersteeg-Kamperman M, Baerts W, Veen S, Samsom JF, Visser GH, van Bel F, Heijnen CJ.
    Pediatrics; 2008 Apr; 121(4):e870-8. PubMed ID: 18381516
    [Abstract] [Full Text] [Related]

  • 12. Fluid balance, respiratory status and limiting the risks of postnatal dexamethasone.
    Greenough A.
    Acta Paediatr; 2001 May; 90(5):592-3. PubMed ID: 11430727
    [No Abstract] [Full Text] [Related]

  • 13. Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia.
    Ohning BL, Fyfe DA, Riedel PA.
    Am Heart J; 1993 Jan; 125(1):253-6. PubMed ID: 8417533
    [No Abstract] [Full Text] [Related]

  • 14. Postnatal corticosteroids in the treatment of chronic lung disease in the preterm infant: past, present, and future.
    Nye J.
    Neonatal Netw; 2007 Jan; 26(5):293-9. PubMed ID: 17926659
    [Abstract] [Full Text] [Related]

  • 15. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
    Hitzert MM, Benders MJ, Roescher AM, van Bel F, de Vries LS, Bos AF.
    Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
    [Abstract] [Full Text] [Related]

  • 16. Dexamethasone therapy interferes with the development of the neutrophil oxidative burst in vitro in very low birthweight infants.
    Ahmad M, Fleit HB, Golightly MG, La Gamma EF.
    Am J Perinatol; 2007 Apr; 24(4):223-5. PubMed ID: 17447193
    [Abstract] [Full Text] [Related]

  • 17. Hemopericardium and cardiac tamponade as presenting findings of dexamethasone-induced hypertrophic cardiomyopathy complicated by transmural myocardial infarction.
    Lilien LD, Lilien RH, Setrakian S.
    Pediatr Cardiol; 2003 Apr; 24(3):280-3. PubMed ID: 12632228
    [Abstract] [Full Text] [Related]

  • 18. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease.
    Lodygensky GA, Rademaker K, Zimine S, Gex-Fabry M, Lieftink AF, Lazeyras F, Groenendaal F, de Vries LS, Huppi PS.
    Pediatrics; 2005 Jul; 116(1):1-7. PubMed ID: 15995023
    [Abstract] [Full Text] [Related]

  • 19. Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth.
    Mieskonen S, Eronen M, Malmberg LP, Turpeinen M, Kari MA, Hallman M.
    Acta Paediatr; 2003 Aug; 92(8):896-904. PubMed ID: 12948063
    [Abstract] [Full Text] [Related]

  • 20. Treatment of hypotension in very low birthweight infants.
    Rajah V.
    Arch Dis Child Fetal Neonatal Ed; 1998 Mar; 78(2):F158. PubMed ID: 9577296
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.